NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
46 hedge funds and large institutions have $14.7M invested in Niagen Bioscience, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
–
Holders Change %
0%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
7
Reduced
14
Closed
16
Calls
$1K
Puts
$47K
Net Calls
-$46K
Net Calls Change
-$46K
Top Buyers
| 1 |
Millennium Management
New York
|
+$779K |
| 2 |
Goldman Sachs
New York
|
+$626K |
| 3 |
ECM
Element Capital Management
New York
|
+$521K |
| 4 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$447K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$406K |
Top Sellers
| 1 |
BlackRock
New York
|
-$4.27M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$950K |
| 3 |
State Street
Boston,
Massachusetts
|
-$891K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$349K |
| 5 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$275K |
